{
    "clinical_study": {
        "@rank": "33566", 
        "acronym": "cat\u00b4sclaw", 
        "arm_group": {
            "arm_group_label": "cat's claw", 
            "arm_group_type": "Experimental", 
            "description": "100 mg dose of a dry extract of U. tomentosa three times per day"
        }, 
        "brief_summary": {
            "textblock": "Cat's claw (Uncaria tomentosa) is a native amazonic plant that exhibits anti-inflammatory\n      and antitumor properties. Patients and methods: This prospective phase II study will assess\n      the effects of a 100-mg dose of a dry extract of U. tomentosa three times per day on\n      individuals with advanced solid tumors, with no further therapeutic options and with at\n      least 2 months life expectancy. In addition, several biochemical and inflammatory parameters\n      will be analyzed."
        }, 
        "brief_title": "Phase II Clinical Trial of Uncaria Tomentosa (Cat\u00b4s Claw) in Patients With Advanced Solid Tumors", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Solid Tumors", 
        "condition_browse": {
            "mesh_term": "Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  individuals with advanced solid tumors, with no further therapeutic options and  with\n             at least 2 moths life expectancy\n\n          -  individuals 18 years of age and older\n\n          -  creatinine levels up to twice the upper limit of normal (ULN)\n\n          -  alanine (ALT) and aspartate (ASP) transaminase levels up to twice the ULN and direct\n             bilirubin (DB) levels up to 1.5 times the ULN\n\n          -  in cases with pre-existing liver disease, the ALT, ASP and DB levels could be up to\n             2.5 times the ULN\n\n        Exclusion Criteria:\n\n          -  pregnant and breastfeeding women\n\n          -  individuals using chemotherapy or other tumor-targeting antineoplastic treatments,\n             except for antalgic radiotherapy\n\n          -  severe kidney or liver failure\n\n          -  known hypersensitiveness to the components of the medication used\n\n          -  past history of emotional disorders that could interfere with the data collection."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "51", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02045719", 
            "org_study_id": "ABC2013"
        }, 
        "intervention": {
            "arm_group_label": "cat's claw", 
            "intervention_name": "uncaria tomentosa (cat\u00b4s claw)", 
            "intervention_type": "Drug", 
            "other_name": "100 mg dose of a dry extract of U. tomentosa three times per day"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "cat\u00b4s claw", 
            "uncaria tomentosa", 
            "quality of life", 
            "no further therapeutic options"
        ], 
        "lastchanged_date": "January 24, 2014", 
        "location": {
            "contact": {
                "email": "lariclpaula@hotmail.com", 
                "last_name": "Larissa de Paula", 
                "phone": "55992951626"
            }, 
            "facility": {
                "address": {
                    "city": "Santo Andr\u00e9", 
                    "country": "Brazil", 
                    "state": "S\u00e3o Paulo", 
                    "zip": "09060-650"
                }, 
                "name": "Centro de Estudos e Pesquisa em Hematologia e Oncologia"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "1", 
        "official_title": "Phase II Clinical Trial of Uncaria Tomentosa (Cat\u00b4s Claw) in Patients With Advanced Solid Tumors", 
        "overall_contact": {
            "email": "lariclpaula@hotmail.com", 
            "last_name": "Larissa de Paula", 
            "phone": "5511992951626"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Assess the efficacy and safety of a dry extract of U. tomentosa on individuals who had solid tumors with no further therapeutic options", 
            "measure": "assessment of benefits on quality of life after treatment during two months", 
            "safety_issue": "Yes", 
            "time_frame": "two months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02045719"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Faculdade de Medicina do ABC", 
            "investigator_full_name": "Felipe Melo Cruz", 
            "investigator_title": "MsC", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Faculdade de Medicina do ABC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Faculdade de Medicina do ABC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}